NCT02586545

Brief Summary

The aim of the study is to test the effect of a new shared care model for type 2 diabetes care and compare it with a standardized care management program in a specialized hospital-based out-patient clinic. The hypothesis is that participants with type 2 diabetes followed in a shared care program will have a comparable outcome in HbA1c to participants receiving standard care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Aug 2015

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 26, 2015

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

January 3, 2019

Status Verified

January 1, 2019

Enrollment Period

3.3 years

First QC Date

October 21, 2015

Last Update Submit

January 2, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline Hemoglobin A, Glycosylated (HbA1c) at 12, 24 and 36 months

    Baseline and follow-up at 12, 24 and 36 months

Secondary Outcomes (1)

  • The proportion of patients who meet national standard indicators reflecting quality of care

    Follow-up at 12, 24 and 36 months after baseline

Other Outcomes (3)

  • Change from baseline Quality of life at 12, 24 and 36 months

    Baseline and follow-up at 12, 24 and 36 months

  • Change from baseline blood pressure at 12, 24 and 36 months

    Baseline and follow-up at 12, 24 and 36 months

  • Change from baseline diabetes symptoms at 12, 24 and 36 months

    Baseline and follow-up at 12, 24 and 36 months

Study Arms (2)

Shared care model

EXPERIMENTAL

Four visits a year: one annual comprehensive check-up at the outpatient diabetes clinic and three quarterly visits at the general practitioner.

Other: Shared care

Mono sectorial care

NO INTERVENTION

Treament as usual including four visits a year with the diabetes team at the outpatient clinic: an annual comprehensive check-up, identical to the one received by the intervention group, and three quarterly visits.

Interventions

Shared care model

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must be over the age of 18 years
  • The diagnosis of type 2 diabetes
  • Risk stratification level 2
  • Capable of speaking and writing in Danish
  • Give oral and written consent before entering the study

You may not qualify if:

  • Diagnosed with other types of diabetes than type 2 diabetes
  • Risk stratification level 1 or 3
  • Being pregnant or breastfeeding
  • Having severe co-morbidity with life expectancy less than five years
  • Being under such conditions, that the patient will not be able to show up or go through with the appointments (e.g. moderate to severe dementia and severe psychiatric conditions)
  • Participating in long-lasting interventions (\>2 weeks) that potentially affects the primary outcome in our study or patients participating in studies which include blood sampling amounting to \>5 % of the blood volume two months prior to the randomisation and/or the follow-up visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Diabetes Research, Gentofte Hospital, University of Copenhagen

Hellerup, DK-2900, Denmark

Location

Related Publications (1)

  • Munch L, Bennich B, Arreskov AB, Overgaard D, Konradsen H, Knop FK, Vilsboll T, Roder ME. Shared care management of patients with type 2 diabetes across the primary and secondary healthcare sectors: study protocol for a randomised controlled trial. Trials. 2016 Jun 4;17(1):277. doi: 10.1186/s13063-016-1409-y.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Lene Munch, MHS, Ph.D.-student

    Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Denmark. Institute of Nursing, University College Metropol, Denmark.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MHS, Ph.D.-student

Study Record Dates

First Submitted

October 21, 2015

First Posted

October 26, 2015

Study Start

August 1, 2015

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

January 3, 2019

Record last verified: 2019-01

Locations